Semaglutide Study Finds Link to Blood Clots A 2021 study published in the Endocrine Journal (Volume 68, Issue 6, pages 739-742) found that type 2 diabetes patients using semaglutide were at a 266% increased risk of deep vein thrombosis
We combine medical expertise with personalized care to ensure each clients weight loss journey is effective and sustainable
Our team provides: One-on-one medical consultations Ongoing progress tracking and support Nutritional guidance and coaching Professional weight loss monitoring When paired with Semaglutide, our holistic approach sets you up for long-term success
Its gained traction in the medical community for its ability to lower blood sugar, or rein in levels of glycated hemoglobin (also known as A1C), often transforming the lives of patients
Data from randomised controlled trials shows that Wegovy generally leads to more weight loss due to the higher doses of semaglutide available
Available in 1 mL vials (5 mg total) and 2 mL vials (10 mg total)